Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nat Commun
2018 Feb 06;91:514. doi: 10.1038/s41467-018-02997-4.
Show Gene links
Show Anatomy links
Cryo-EM structure of 5-HT3A receptor in its resting conformation.
Basak S
,
Gicheru Y
,
Samanta A
,
Molugu SK
,
Huang W
,
Fuente M
,
Hughes T
,
Taylor DJ
,
Nieman MT
,
Moiseenkova-Bell V
,
Chakrapani S
.
???displayArticle.abstract???
Serotonin receptors (5-HT3AR) directly regulate gut movement, and drugs that inhibit 5-HT3AR function are used to control emetic reflexes associated with gastrointestinal pathologies and cancer therapies. The 5-HT3AR function involves a finely tuned orchestration of three domain movements that include the ligand-binding domain, the pore domain, and the intracellular domain. Here, we present the structure from the full-length 5-HT3AR channel in the apo-state determined by single-particle cryo-electron microscopy at a nominal resolution of 4.3 Å. In this conformation, the ligand-binding domain adopts a conformation reminiscent of the unliganded state with the pore domain captured in a closed conformation. In comparison to the 5-HT3AR crystal structure, the full-length channel in the apo-conformation adopts a more expanded conformation of all the three domains with a characteristic twist that is implicated in gating.
Fig. 1. Cryo-EM structure of apo-5-HT3AR. a The 3D reconstruction map from the full-length 5-HT3AR at 4.3âà resolution. The views, going from left to right, are parallel to the membrane (side view), from the extracellular side (top view), and from the intracellular side (bottom view). Individual subunits are depicted in different colors, and the three domains are labeled. The solid lines denote putative membrane limits. b Cartoon representations of the 5-HT3AR structural model based on the EM reconstruction. The views correspond to the orientations shown in a. For each subunit, three sets of glycans (green) and one lipid (brown) molecule are shown as stick representation
Fig. 2. Alignment of the apo-5-HT3AR with the crystal structure of nanobody-bound 5-HT3AR. a A view of the ECDs from the extracellular end when aligned with respect to the TMDs (left). The view of the TMDs from the intracellular end when aligned with respect to the ECDs (right). The apo-5-HT3AR structure and the 5-HT3AR crystal structure are shown in salmon red and pale green, respectively. The arrows show the putative direction of displacements between the two structures. b A comparison of the ECD of the apo-structure with the crystal structure when aligned with respect to the TMD of the (â) subunit (left). A comparison of the TMD between the two structures when aligned with the ECD of the (â) subunit. The relative tilt of the axis parallel to the TM helices between the two structures are indicated. The dotted lines highlight the differences in the intrasubunit cavity volume. The spheres indicate the position of residues M1 (Leu227), M2 (Leu266), M3 (Met291), and M4 (Trp456). The arrows show the putative direction of displacements between the two structures (right). The alignment in b highlights the relative changes in the two structures, both with respect to the neighboring subunit, as well as with respect to the other domain
Fig. 3. Profile of ion permeation pathway. a The pore profile generated by the HOLE program60 depicts an ion permeation pathway of ~165âà encompassing the ECD, TMD, and the ICD. Only two subunits are shown for clarity. Sidechains of residues that line the constricted areas are shown as sticks. b A comparison of the pore radii along the pore axis for the 5-HT3AR cryo-EM structure (salmon red) with that of the crystal structure (pale green). The dashed line indicates an approximate radius of a hydrated Na+ ion35. The pore is constricted below 3âà radius at three sites: L260 and E250 along M2 and R416 in the ICD. c Non-protein densities along the pore axis were modeled as water (red), Na+ (magenta), and Clâ (green). The map around the ions is shown as a mesh representation calculated at various Ï values (outer water ring: 4 Ï; inner water ring:5 Ï; Na+ ion: 6 Ï; Clâ ion: 7 Ï)
Fig. 4. The neurotransmitter binding site. a The map around the aromatic residues at the subunit interface that constitutes the neurotransmitter binding site (top). The map for the residues in Loop F that are involved in ligand binding (bottom). b Alignment of 5-HT3AR apo (salmon red) and crystal (pale green) structures reveals a twist and an expansion at the region lined Loop C, Loop B, and Loop F. The arrows indicate the direction of movement. c A comparison of the orientations of the residues that are involved in neurotransmitter binding
Fig. 5. The Intracellular domain. a The ICD is comprised of the post-M3 loop, the MX, helix, a stretch of unstructured region, followed by the MA helix. The density from the MX helix is bent downward to the intracellular end of the MA helix, but the unstructured region is not resolved. Superposition of the 5-HT3AR apo and crystal structures reveals differences in the conformation of ICD in the two structures. The (â) subunit of the two structures are aligned. The expansion of the ICD resulting from an outward displacement of MA and MX helices are indicated by arrows. b The residues within the ICD involved in several potential intra and inter-subunit interactions. c The solvent-accessible electrostatic potential map generated using the APBS tool. The inset shows a zoomed-in view of the lipid-binding pocket within the dotted green box. The lipid (partially built phospholipid) and the interacting residues (R306 and R435) are shown in stick. The map around the lipid is shown as blue mesh
Adams,
PHENIX: building new software for automated crystallographic structure determination.
2002, Pubmed
Adams,
PHENIX: building new software for automated crystallographic structure determination.
2002,
Pubmed
Althoff,
X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors.
2014,
Pubmed
Baker,
Electrostatics of nanosystems: application to microtubules and the ribosome.
2001,
Pubmed
Baptista-Hon,
The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.
2013,
Pubmed
Basak,
Crystal structure and dynamics of a lipid-induced potential desensitized-state of a pentameric ligand-gated channel.
2017,
Pubmed
Brams,
A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors.
2011,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Carland,
Mutagenic analysis of the intracellular portals of the human 5-HT3A receptor.
2013,
Pubmed
Chang,
Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism.
2002,
Pubmed
,
Xenbase
Chen,
MolProbity: all-atom structure validation for macromolecular crystallography.
2010,
Pubmed
Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed
Connolly,
Trafficking of 5-HT(3) and GABA(A) receptors (Review).
2008,
Pubmed
Costall,
5-HT3 receptors.
2004,
Pubmed
daCosta,
A distinct mechanism for activating uncoupled nicotinic acetylcholine receptors.
2013,
Pubmed
Davies,
The 5-HT3B subunit is a major determinant of serotonin-receptor function.
1999,
Pubmed
,
Xenbase
Du,
Glycine receptor mechanism elucidated by electron cryo-microscopy.
2015,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Engel,
The serotonin 5-HT3 receptor: a novel neurodevelopmental target.
2013,
Pubmed
Gehlert,
Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
1991,
Pubmed
Gershon,
Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
2004,
Pubmed
Grosman,
The extracellular linker of muscle acetylcholine receptor channels is a gating control element.
2000,
Pubmed
Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed
Hassaine,
X-ray structure of the mouse serotonin 5-HT3 receptor.
2014,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hilf,
X-ray structure of a prokaryotic pentameric ligand-gated ion channel.
2008,
Pubmed
Kato,
Role of serotonin 5-HT₃ receptors in intestinal inflammation.
2013,
Pubmed
Kucukelbir,
Quantifying the local resolution of cryo-EM density maps.
2014,
Pubmed
Lee,
Nicotinic receptor interloop proline anchors beta1-beta2 and Cys loops in coupling agonist binding to channel gating.
2008,
Pubmed
Lee,
Water polygons in high-resolution protein crystal structures.
2009,
Pubmed
Livesey,
Rings of charge within the extracellular vestibule influence ion permeation of the 5-HT3A receptor.
2011,
Pubmed
Lummis,
5-HT(3) receptors.
2012,
Pubmed
MacKenzie,
Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides.
1984,
Pubmed
Maricq,
Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.
1991,
Pubmed
,
Xenbase
Miller,
Crystal structure of a human GABAA receptor.
2014,
Pubmed
Miller,
Structural basis for GABAA receptor potentiation by neurosteroids.
2017,
Pubmed
Mindell,
Accurate determination of local defocus and specimen tilt in electron microscopy.
2003,
Pubmed
Monk,
Identification and importance of N-glycosylation of the human 5-hydroxytryptamine3A receptor subunit.
2004,
Pubmed
Morales-Perez,
X-ray structure of the human α4β2 nicotinic receptor.
2016,
Pubmed
Niesler,
Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E.
2003,
Pubmed
Noam,
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates.
2008,
Pubmed
Panicker,
Evidence for a centrally located gate in the pore of a serotonin-gated ion channel.
2002,
Pubmed
,
Xenbase
Perwitasari,
Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.
2011,
Pubmed
Peters,
The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
2004,
Pubmed
Pless,
Ligand-specific conformational changes in the alpha1 glycine receptor ligand-binding domain.
2009,
Pubmed
,
Xenbase
Potter,
Leginon: a system for fully automated acquisition of 1000 electron micrographs a day.
1999,
Pubmed
Price,
Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP.
2015,
Pubmed
,
Xenbase
Sauguet,
Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation.
2014,
Pubmed
,
Xenbase
Sauguet,
Structural basis for ion permeation mechanism in pentameric ligand-gated ion channels.
2013,
Pubmed
,
Xenbase
Scheres,
Processing of Structurally Heterogeneous Cryo-EM Data in RELION.
2016,
Pubmed
Sine,
On the origin of ion selectivity in the Cys-loop receptor family.
2010,
Pubmed
Smart,
HOLE: a program for the analysis of the pore dimensions of ion channel structural models.
1996,
Pubmed
Spiller,
Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.
2011,
Pubmed
Tang,
EMAN2: an extensible image processing suite for electron microscopy.
2007,
Pubmed
Thompson,
A single ring of charged amino acids at one end of the pore can control ion selectivity in the 5-HT3 receptor.
2003,
Pubmed
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Yu,
Agonist and antagonist binding in human glycine receptors.
2014,
Pubmed
Zhang,
Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator.
2016,
Pubmed
Zheng,
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.
2017,
Pubmed
Zhong,
From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor.
1998,
Pubmed